Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

PLC (NASDAQ:SMX) is driving a global transition toward material efficiency as volatile oil and gas markets increase the cost of producing plastics and synthetic materials-placing rising pressure on ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused on Reliable Endotoxin Testing For Injectable Pharmaceuticals, a systematic ...

The biotechnology company, which develops genetically engineered silkworms, says it is moving toward commercial production of ...

In the volatile world of technology stocks, the goal is to stand alone as the market leader, or at the very least excel as a top competitor, with proven products capable of turning a profit while ...

In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...

Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine ...

Allied Market Research published a report, titled, "Fibrinogen Concentrate Market by Product Type (Human Fibrinogen Concentrate, Re ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine ...